气喘·COPD的全球市场:各药物类型，各疾病类型，各流通管道，各地区-规模，占有率，展望，机会分析(2022年～2028年)

本报告提供全球气喘·COPD市场的相关调查，提供市场展望，市场动态，市场分析，竞争情形等全面性资讯。

目录

第1章 调查目的·前提条件

• 调查目的
• 假设
• 简称

第2章 市场展望

• 报告的说明
  • 市场定义和范围
• 摘要整理
  • 市场明细:各药物类型
  • 市场明细:各疾病类型
  • 市场明细:各流通管道
• 连贯机遇地图(COM)

第3章 市场动态，法规，及趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 主要的开发
• 法规方案
• PEST分析
• COVID-19影响分析

第4章 全球气喘·COPD市场:各药物类型(100万美元)(2017年～2028年)

• 简介
  • 市场占有率分析(%)(2022年～2028年)
  • 与前一年同期比较成长分析(2017年～2028年)
  • 市场区隔趋势
• 支气管扩张药
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
  • 市场区隔趋势
• 短效型支气管扩张药
• 长效型支气管扩张药
• 抗胆碱促效剂
• 抗发炎剂
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
  • 市场区隔趋势
• 吸入皮质类固醇
• 抗白三烯
• 单株抗体
• 联合治疗
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
  • 市场区隔趋势

第5章 全球气喘·COPD市场:各疾病类型(100万美元)(2017年～2028年)

• 简介
  • 市场占有率分析(%)(2022年～2028年)
  • 与前一年同期比较成长分析(2017年～2028年)
  • 市场区隔趋势
• 气喘
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
• COPD
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)

第6章 全球气喘·COPD市场:各流通管道(100万美元)(2017年～2028年)

• 简介
  • 市场占有率分析(%)(2022年～2028年)
  • 与前一年同期比较成长分析(2017年～2028年)
  • 市场区隔趋势
• 医院药局
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
• 零售药局
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
• 线上药局
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)
• 药妆店
  • 简介
  • 市场规模与预测，及与前一年同期比较成长率(100万美元)(2017年～2028年)

第7章 全球气喘·COPD市场:各地区(100万美元)(2017年～2028年)

• 简介
  • 市场占有率分析(%)(2022年～2028年)
  • 与前一年同期比较成长分析(2017年～2028年)
  • 市场区隔趋势
• 北美
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他的欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东南亚国协
• 澳洲
• 韩国
• 其他的亚太地区
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美
• 中东
• GCC各国
• 以色列
• 其他的中东
• 非洲
• 北非
• 中非
• 南非

第8章 竞争情形

• 企业简介
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline plc
• Merck &Co., Inc.
• Verona Pharma plc
• Regeneron Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH

第9章 章节

• 参考文献
• 调查手法
• 关于本公司和营业窗口

Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.

Restraints of the Global Asthma and COPD Market

Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.

Key features of the study:

• This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global asthma and COPD market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

• Global Asthma and COPD Market, By Drug Type:
  • Bronchodilators
• Short Acting Bronchodilators
• Long Acting Bronchodilators
• Anticholinergics
  • Anti-Inflammatories
• Inhaled Corticosteroids
• Anti-Leukotriene
• Monoclonal Antibodies
  • Combination Therapies
• Global Asthma and COPD Market, By Disease Type:
  • Asthma
  • COPD
• Global Asthma and COPD Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• Global Asthma and COPD Market, By Geography:
  • North America
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • U.S.
  • Canada
  • Europe
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
• Company Profiles
  • AstraZeneca PLC*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
  • Novartis AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Verona Pharma plc
  • Regeneron Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
  • Executive Summary
• Market Snippet, By Drug Type
• Market Snippet, By Disease Type
• Market Snippet, By Distribution Channel
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • COVID-19 Impact Analysis

4. Global Asthma and COPD Market, By Drug Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Bronchodilators
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Short Acting Bronchodilators
  • Long Acting Bronchodilators
  • Anticholinergics
  • Anti-Inflammatories
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Inhaled Corticosteroids
  • Anti-Leukotriene
  • Monoclonal Antibodies
  • Combination Therapies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends

5. Global Asthma and COPD Market, By Disease Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Asthma
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • COPD
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Asthma and COPD Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Drug Stores
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Asthma and COPD Market, By Regions, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Company Profiles
• AstraZeneca PLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Verona Pharma plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Regeneron Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact